Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Clinical Immunology (Orlando, Fla.)|August 26, 2011
Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEXKimberly A Kasow, Vanessa M Morales-Tirado, David Wichlan, et al.Blood Advances|October 14, 2022
Reduction in vaso-occlusive events following stem cell transplantation in patients with sickle cell diseaseAlexis Leonard, Dana Furstenau, Allistair Abraham, et al.Cytotherapy|March 25, 2022
An ISCT Stem Cell Engineering Committee Position Statement on Immune Reconstitution: the importance of predictable and modifiable milestones of immune reconstitution to transplant outcomesAlice Bertaina, Allistair Abraham, Carmem Bonfim, et al.Cytotherapy|December 9, 2021
Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantationAlexis Leonard, Alice Bertaina, Carmem Bonfim, et al.British Journal of Haematology|November 2, 2019
Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell diseaseRobert S Nickel, John T Horan, Allistair Abraham, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 14, 2017
Lentiviral Transfer of γ-Globin with Fusion Gene NUP98-HOXA10HD Expands Hematopoietic Stem Cells and Ameliorates Murine β-ThalassemiaHui Fen Zhao, Allistair Abraham, Yoon-Sang Kim, et al.Transplantation and Cellular Therapy|September 16, 2021
Low Rates of Cerebral Infarction after Hematopoietic Stem Cell Transplantation in Patients with Sickle Cell Disease at High Risk for StrokeJessica L Carpenter, Robert S Nickel, Jennifer Webb, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2017
Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell DiseaseAllistair Abraham, Matthew Hsieh, Mary Eapen, et al.Cytotherapy|December 6, 2023
Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyondSafia Belbachir, Allistair Abraham, Akshay Sharma, et al.Cytotherapy|June 15, 2022
Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatmentMaja Stanojevic, Alice Bertaina, Carmem Bonfim, et al.Pageof 5